Log in to save to my catalogue

Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonis...

Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotraccpiq_697852666

Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring

About this item

Full title

Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring

Publisher

Canadian Urological Association

Journal title

Canadian Urological Association journal, 2022-03, Vol.16 (3), p.E146

Language

English

Formats

Publication information

Publisher

Canadian Urological Association

More information

Scope and Contents

Contents

Introduction: In light of COVID-19, reducing patient exposure via remote monitoring is desirable. Patients prescribed abiraterone/enzalutamide are scheduled for monthly in-person appointments to screen for adverse events (AEs). We determined time trends of drug-specific actionable AEs among users of abiraterone/enzalu-tamide to assess the safety of...

Alternative Titles

Full title

Time trends of drug-specific actionable adverse events among patients on androgen receptor antagonists: Implications for remote monitoring

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotraccpiq_697852666

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotraccpiq_697852666

Other Identifiers

ISSN

1911-6470

E-ISSN

1920-1214

DOI

10.5489/cuai.7437

How to access this item